Transformation of views on the teratogenic effects of antiepileptic drugs
Abstract
This review presents information on pharmaceuticals that have the properties of inverse agonists. The article describes the features of the interaction of the ligand - receptor with constitutive conformational changes. Many of ligands, assumed to be neutral antagonists, behave as inverse agonists displaying negative efficacy in experimental systems. This suggests that their therapeutic actions may involve not only receptor blockade, but also the decrease of spontaneous receptor activity. Examples of inverse agonists that influence the processes of excitation of adrenergic, histaminergic, opioid and benzodiazepine receptors are presented. The existence of constitutive activity in vivo and its pathophysiological relevance are also discussed
About the Authors
E. Yu. Пастернак
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
R. N. Alyautdin
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
B. K. Romanov
Scientific Centre for Expert Evaluation of Medicinal Products Russian Federation
Russian Federation
Russian Federation
References
1. Prakash, Prabhu L V, Nasar M A, Rai R, Madhyastha S, Singh G. Lamotrigine in pregnancy: safety profile and the risk of malformations. Singapore Med J 2007; 48 (10) : 880.
2. Meadow, S.R. (1968) Anticonvulsant drugs and congenital abnormalities. Lancet 292: 1296.
3. Quality Standarts Subcommittee of the American Academy of Neurology. Practice parameter: Man agement issues for women with epilepsy(summary statement). Neurology 1998;51:944-8.
4. Webber MP, Hauser WA, Ottmann R, Annegers JF.Fertility in persons with epilepsy: 1935–1974 . Epilepsia. 1986;27:746–752.
5. Dansky LV, Andermann E, Andermann F. Marriage and Fertility in epileptic patients. Epilepsia. 1980;21:261–271.
6. Schupf N, Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy; risk factors for reduced fertility in marriage. Epilepsia. 1996; 37: 833–840.
7. Cogen PH, Antunes JL, Correll JW. Reproductive function in temporal lobe epilepsy: the effect of temporal lobectomy. Surg Neurol. 1979; 12: 243–246.
8. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch Neurol. 1986; 43: 347-350.
9. Bilo L, Meo L, Nappi C, et al. Reproductive endocrine disorders in women primary generalized epilepsy. Epilepsia. 1988; 29: 612–619.
10. Isojarvi JL, Laatikainen TJ, Pakarinen, Juntunnen KT, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J 1993;329: 1283–1388.
11. Morrell MJ, Springer E, Giudice L. Reproductive function in women with epilepsy on including ahd nonincluding antiepileptic drugs. Epilepsia. 1997; 38: 232.
12. Aull-Watschinger S. Fertilitat and Schwangerschaft. In: Baumgartner, C, ed., Handbuch der Epili psen. Vienn a, Austria; New York, NY: Springer; 2001: 971–977.
13. Penovich PE. The effect of epilepsy and its treatment on sexual and reproductive functions. Epilepsia. 2000; 41: 53–61.
14. Bauer J. Epilepsie, Schwangerschaft und Sexualitat. Darmstad, Germany: Steinkopff; 2005.
15. Schmitz I, Janzik HH, Mayer K. Personlichkeitsstruktur und Sexualverhalten Anfallskranker unter Langzeitbehandlung mit DPH. Bibl Psychiatr. 1975; 151: 176–181.
16. Luhdorf K, Hareskov C, Lund M, Hansen JM, Christiansen P.A prospective study od the side-effects of antiepileptic drugs with special reference to exrection of androgens and cortisol. In: Penry JK, eds. Epilepsy: The VIIIth Intern ation al Symposium, New York, NY: Paven Press; 1977: 209–213.
17. London DR, Loizou LA, Butt WR, Rovei V, Bianchetti G, Morselli PL. The effect of anto-convulsant drugs (AED) on hormon al responses in normal voluntrees. In: Johanssen Sl, Morselli PL, Pi ppenger CE, Richens A, Schmidt D, Mein ardi H, eds. Antiepileptic
18. Therapy: Advances in Drug Monitoring, New York, NY: Raven Press; 1980: 405–411.
19. Franceshi M, Perego L, Cavagnini F, et al. Effects of long-term antiepileptic therapy on the hypothalamic-pituitary axis in man. Epilepsia 1984; 25: 46–52.
20. Isojarvi JIT. Serum steroid hormones and pituitary function in female epileptic during patients during carbamazepine therapy. Epilepsia. 1990; 31: 438–445.
21. Page B. Pennell. Antiepileptic drugs during pregn ancy: What is known and which AEDs seem to be safest? Epilepsia. 2008 December ; 49 (09).
22. Bassi V, Yerby MS, Devinsky O. Epilepsy. In: Hainline B, Devinsky O, eds. Neurological Complications of Pregn ancy, 2nd ed. Philadelphia, Pa: Li ppincott Williams& Williams; 2002: 185–212.
23. Frosher W. Antiepileptika- Therapie in der Schwangerschaft, Missbildungen, Wachstmusund Entwicklungsstorungen. In: Froscher W, Vasella F, Hufn agel A, eds. Doe Epilepsen.
24. Grundlagen- Klinik- Behandlung.2. Stuttgart, Germany; New York, NY: Schattauer ; 2004; 657–667.
25. Crawford P. Epilepsy and pregn ancy. Seizure. 2001; 10: 212–219.
26. Dean JCS, Hailey H, Moore SJ, Lloyd DJ, Turnpenny PD, Little J. Long term health and neurodevelopment in children exposed and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002; 39, 251–259.
27. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001; 344: 1132–1138.
28. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res. 1999; 33: 145–158.
29. Samren EB, van Duijin CM, Koch S, et al. Matern al use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenes associated with matern al epilepsy. Epilepsia. 1997; 38: 381–390.
30. Frosher W. Teratogenic effects of antiepileptic drugs. Drugs Today. 1989; 25: 563–567.
31. Holmes LB, Harvey EA, Coull BA, et al.The teratogenicity of anticonvulsant drugs. N Engl Med. 2001; 344: 1132-1138.
32. Dolk, H McElhatton, P.Assessing epidemiological evidence for the teratogenic effects of antoconvulsant medication. J Med Genet. 2002, 39: 243–244.
33. Beyenburg S, Bauer J. Spezifische Aspekte der Beratung und Behandlung von Frauen mit Epilepsie. Nervenheilkude. 2001; 20: 499–505.
34. Астахова А.В., Ушкалова Е.А. Побочные реакции, вызываемые противосудорожными средствами у детей. Безопасность лекарств 1997; 2: 5–12.
35. Kaplan PW. Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 2004; 63:S13–23.
36. Anonymus. Antiepileptics, pregn ancy and the child. Drug Ther Rul 2005; 43:13–16.
37. Электронный ресурс регуляторного органа США (FDA) http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/010151s037lbl.pdf.
38. Электронный ресурс Medicines and Healthcare products Regulatory Agency http://www.mhra.gov.uk/home/groups/l-unit1/documents/websiteresources/con2024816.pdf.
39. Лепахин В.К., Романов Б.К., Торопова И.А. Анализ сообщений о нежелательных реакциях на лекарственные средства / Ведомости Ведомости Научного центра экспертизы средств медицинского применения. 2012, №1. C. 22–26.
40. Лепахин В.К., Романов Б.К., Никитина Т.Н., Снегирева И.И. Экспертиза оценки отношения ожидаемой пользы к возможному риску применения лекарственных средств / Ведомости Научного центра экспертизы средств медицинского применения. 2012. №
41. С. 19–21.
42. Morrow J Russel A. Guthrie E. et al. Malformation risks og antiepileptic drugs in pregn ancy: a prospective study from the UK Epilepsy and Pregn ancy Register J Neurol Neurosurg Psychiatry 2006; 77: 193–198.
43. Richens A. Safety of lamotrigine. Epilepsia 1994; 35 suppl 5: S37–40
44. Denise S Hill, Bogdan J Wlodarczyk, An a M Palacios, Richard H Finnell Teratogenic effects of antiepileptic drugs Exper Rev Neurother. 2010 ; 10(6): 943–59.
Review
For citations:
E.Yu., Alyautdin R.N., Romanov B.K. Transformation of views on the teratogenic effects of antiepileptic drugs. Safety and Risk of Pharmacotherapy. 2014;(4):12-17. (In Russ.)
Views:
582
Email this article 